Sort   by:  
 Page size 
UnknownCisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.
Not available
S-EPMC3221525 | biostudies-literature
UnknownChemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Not available
S-EPMC4429175 | biostudies-literature
UnknownRandomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
Not available
S-EPMC3157978 | biostudies-literature
UnknownPhase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Not available
S-EPMC4876357 | biostudies-literature
UnknownRandomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.
Not available
S-EPMC3397694 | biostudies-literature
UnknownPhase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Not available
S-EPMC5493050 | biostudies-literature
UnknownMulticenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Not available
S-EPMC3397785 | biostudies-literature
UnknownNivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Not available
S-EPMC6075826 | biostudies-literature
Sort   by:  
 Page size